Riverview Trust Company’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-3,237
Closed -$15.9K 671
2024
Q1
$15.9K Buy
+3,237
New +$15.9K 0.01% 575